Related Experiment Video
Updated: Jul 18, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Indolent lymphomas: current and emerging treatment approaches
David Maloney1, Brad S Kahl, Martin Dreyling
1Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington 98109, USA.
Clinical Advances in Hematology & Oncology : H&O
|December 2, 2006
Summary
Targeted therapy, including rituximab, is improving indolent lymphoma treatment, offering hope for curative options. Research is exploring optimal use of these agents, potentially transforming outcomes from palliative to curative.
Area of Science:
- Hematology
- Oncology
- Immunotherapy
Background:
- Indolent lymphomas, particularly follicular lymphoma, have seen significant treatment advancements.
- Targeted therapies, especially monoclonal antibodies like rituximab, are central to these improvements.
Purpose of the Study:
- To review the impact of targeted therapy combined with chemotherapy in indolent lymphomas.
- To discuss the evolving role of rituximab and other novel agents in follicular lymphoma treatment.
Main Methods:
- Review of recent clinical studies and ongoing research in indolent lymphoma treatment.
- Analysis of data on response rates, progression-free survival, and overall survival.
Main Results:
- Rituximab has improved response rates and survival in follicular lymphoma patients.
- Combination therapies and maintenance strategies are showing promising results.
Conclusions:
- Targeted agents are shifting indolent lymphoma treatment paradigms.
- Future strategies will likely involve personalized immunochemotherapy based on risk profiles.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...